Live Breaking News & Updates on Emily Adhikari

Stay updated with breaking news from Emily adhikari. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID SCIENCE-Delta increases COVID-19 risks for pregnant women; Pfizer/BioNTech vaccine antibodies gone by 7 months for many

"These findings suggest that administering a booster dose at around 6 to 7 months following the initial immunization will likely enhance protection against SARS-CoV-2 and its variants." Experimental Merck pill halves hospitalizations, deaths Merck & Co's experimental oral antiviral drug for COVID-19, molnupiravir, reduced by around 50% the chance of hospitalization or death for patients with mild or moderate infections who had risk factors for severe disease, according to interim clinical trial results announced by the company https://bit.ly/3zVtyE5 on Friday. ....

United States , University Of Texas Southwestern Medical Center , Mehul Suthar , Amesh Adalja , Ridgeback Biotherapeutics , Emily Adhikari , Bali Pulendran , Us Centers For Disease , Emory University , Merck Co , Pfizer Inc , Johns Hopkins Center , Health Security , Stanford University , American Journal , Texas Southwestern Medical Center , Disease Control ,